Market Research Report
Global Cardiac Pacemaker Devices Market Analysis (2017-2023)
|Published by||KBV Research||Product code||644797|
|Published||Content info||178 Pages
|Global Cardiac Pacemaker Devices Market Analysis (2017-2023)|
|Published: May 17, 2018||Content info: 178 Pages||
The Global Cardiac Pacemaker Market size is expected to reach $4.8 billion by 2023, rising at a market growth of 3.9% CAGR during the forecast period.
A pacemaker is an electrical device and it is used to treat arrhythmias, which leads to irregular heartbeat. A pacemaker is generally used to help patients suffering from arrhythmias, to lead an active and healthy life style.
Implantable cardiac pacemakers have been witnessing significant demand due to growing cases of slow heart rhythm and cardiac failures. Additionally, technological advancements such as development of MRI compatible pacemakers have further driven the growth of the market. Growing prevalence of cardiovascular disorders in developed nations, rapidly growing cases of cardiac disease in underdeveloped nations, supportive government initiatives, and non-government organizations funding are the factors that are driving the growth of the cardiac pacemaker market.
Based on product, the market report segments the market into Implantable cardiac pacemakers and External cardiac pacemakers. Based on technology, the market covers Single-chamber cardiac pacemakers, Dual-chamber cardiac pacemakers, and Bi-ventricular cardiac pacemakers. The end user segment covers Hospitals, Cardiac Center & Clinics, and Ambulatory Surgical Centers (ASCs). Based on Regions, the Cardiac Pacemaker market segments the market into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the Global Cardiac Pacemaker Market. Key companies profiled in the report include Abbott Laboratories (U.S.), Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co ltd, Cook Medical Group, Medico S.p.A, LivaNova PL, Osypka Medical GmbH, Shree Pacetronix Ltd., and Medline Industries, Inc.